XTX Topco’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$994K Buy
+85,331
New +$1.22M 0.01% 1791
2026
Q1
Sell
-54,273
Closed -$870K 3893
2025
Q4
$870K Buy
54,273
+28,541
+111% +$425K 0.02% 1130
2025
Q3
$318K Sell
25,732
-22,776
-47% -$267K 0.02% 1469
2025
Q2
$559K Buy
48,508
+38,168
+369% +$453K 0.02% 1010
2025
Q1
$155K Buy
+10,340
New +$173K 0.01% 1759
2024
Q2
Sell
-12,289
Closed -$210K 1940
2024
Q1
$210K Buy
+12,289
New +$193K 0.03% 1136
2023
Q4
Sell
-8,357
Closed -$201K 1662
2023
Q3
$201K Buy
+8,357
New +$205K 0.03% 1017
2022
Q4
Sell
-10,778
Closed -$145K 1165
2022
Q3
$145K Buy
+10,778
New +$182K 0.04% 873
2021
Q3
Sell
-7,812
Closed -$304K 737
2021
Q2
$304K Buy
+7,812
New +$280K 0.1% 356

Other funds holding CLB

XTX Topco's CLB Position: Q2 2026 in Review

XTX Topco opened a new position in Core Laboratories (CLB) in Q2 2026: 85,331 shares worth $994K. The stake represents 0.01% of the portfolio and ranks #1791 among its holdings. This is a return to the name: XTX Topco previously reported a position in CLB as recently as Q4 2025.

XTX Topco first reported a position in CLB in Q2 2021 and has held it in 9 quarters since. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • XTX Topco held 85,331 shares of Core Laboratories worth $994K as of Q2 2026.
  • Core Laboratories was a new XTX Topco position in Q2 2026.
  • Core Laboratories made up 0.01% of XTX Topco's portfolio in Q2 2026, its #1791 holding.
  • XTX Topco first reported a position in Core Laboratories in Q2 2021 and has held it in 9 quarters since.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.